These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 27390349)

  • 1. Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome.
    Gasparotto D; Rossi S; Polano M; Tamborini E; Lorenzetto E; Sbaraglia M; Mondello A; Massani M; Lamon S; Bracci R; Mandolesi A; Frate E; Stanzial F; Agaj J; Mazzoleni G; Pilotti S; Gronchi A; Dei Tos AP; Maestro R
    Clin Cancer Res; 2017 Jan; 23(1):273-282. PubMed ID: 27390349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
    Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
    Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
    Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
    Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1.
    Stewart DR; Corless CL; Rubin BP; Heinrich MC; Messiaen LM; Kessler LJ; Zhang PJ; Brooks DG
    J Med Genet; 2007 Jan; 44(1):e61. PubMed ID: 17209131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of Gastrointestinal Stromal Tumors: A Heterogeneous Family of Tumors?
    Patil DT; Rubin BP
    Surg Pathol Clin; 2015 Sep; 8(3):515-24. PubMed ID: 26297068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal neurofibromatosis is a subtype of familial GIST and results from a dominant activating mutation in PDGFRA.
    de Raedt T; Cools J; Debiec-Rychter M; Brems H; Mentens N; Sciot R; Himpens J; de Wever I; Schöffski P; Marynen P; Legius E
    Gastroenterology; 2006 Dec; 131(6):1907-12. PubMed ID: 17087943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients.
    Maertens O; Prenen H; Debiec-Rychter M; Wozniak A; Sciot R; Pauwels P; De Wever I; Vermeesch JR; de Raedt T; De Paepe A; Speleman F; van Oosterom A; Messiaen L; Legius E
    Hum Mol Genet; 2006 Mar; 15(6):1015-23. PubMed ID: 16461335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen's disease).
    Takazawa Y; Sakurai S; Sakuma Y; Ikeda T; Yamaguchi J; Hashizume Y; Yokoyama S; Motegi A; Fukayama M
    Am J Surg Pathol; 2005 Jun; 29(6):755-63. PubMed ID: 15897742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours.
    Agaimy A; Terracciano LM; Dirnhofer S; Tornillo L; Foerster A; Hartmann A; Bihl MP
    J Clin Pathol; 2009 Jul; 62(7):613-6. PubMed ID: 19561230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of an Italian series of sporadic GISTs.
    Origone P; Gargiulo S; Mastracci L; Ballestrero A; Battistuzzi L; Casella C; Comandini D; Cusano R; Dei Tos AP; Fiocca R; Garuti A; Ghiorzo P; Martinuzzi C; Toffolatti L; ; Bianchi Scarrà G
    Gastric Cancer; 2013 Oct; 16(4):596-601. PubMed ID: 23291969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors.
    Jasek K; Buzalkova V; Minarik G; Stanclova A; Szepe P; Plank L; Lasabova Z
    Virchows Arch; 2017 Jan; 470(1):29-36. PubMed ID: 27864688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Study of Chinese Quadruple-negative GISTs Using Next-generation Sequencing Technology.
    Wang S; Sun RZ; Han Q; Wang SY; Wang EH; Liu Y
    Appl Immunohistochem Mol Morphol; 2021 Jan; 29(1):34-41. PubMed ID: 33002893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients.
    Kang DY; Park CK; Choi JS; Jin SY; Kim HJ; Joo M; Kang MS; Moon WS; Yun KJ; Yu ES; Kang H; Kim KM
    Am J Surg Pathol; 2007 Feb; 31(2):224-32. PubMed ID: 17255767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors.
    Belinsky MG; Rink L; Flieder DB; Jahromi MS; Schiffman JD; Godwin AK; von Mehren M
    Genes Chromosomes Cancer; 2013 Feb; 52(2):214-24. PubMed ID: 23109135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and clinicopathological features of KIT/PDGFRA wild-type gastrointestinal stromal tumors.
    Nishida T; Naito Y; Takahashi T; Saito T; Hisamori S; Manaka D; Ogawa K; Hirota S; Ichikawa H
    Cancer Sci; 2024 Mar; 115(3):894-904. PubMed ID: 38178783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based study.
    Rossi S; Gasparotto D; Miceli R; Toffolatti L; Gallina G; Scaramel E; Marzotto A; Boscato E; Messerini L; Bearzi I; Mazzoleni G; Capella C; Arrigoni G; Sonzogni A; Sidoni A; Mariani L; Amore P; Gronchi A; Casali PG; Maestro R; Dei Tos AP
    Am J Surg Pathol; 2015 Jul; 39(7):922-30. PubMed ID: 25970686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG study.
    Capelli L; Petracci E; Quagliuolo V; Saragoni L; Colombo P; Morgagni P; Calistri D; Tomezzoli A; Di Cosmo M; Roviello F; Vindigni C; Coniglio A; Villanacci V; Catarci M; Coppola L; Alfieri S; Ricci R; Capella C; Rausei S; Gulino D; Amadori D; Ulivi P;
    Eur J Surg Oncol; 2016 Aug; 42(8):1206-14. PubMed ID: 27265040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases.
    Miettinen M; Fetsch JF; Sobin LH; Lasota J
    Am J Surg Pathol; 2006 Jan; 30(1):90-6. PubMed ID: 16330947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of gastrointestinal stromal tumor syndromes.
    Gopie P; Mei L; Faber AC; Grossman SR; Smith SC; Boikos SA
    Endocr Relat Cancer; 2018 Feb; 25(2):R49-R58. PubMed ID: 29170162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
    Liegl B; Hornick JL; Corless CL; Fletcher CD
    Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.